[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338929-105":59,"doc-detail-338929-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","gut-microbiota-and-dietary-intervention-affecting-immunotherapy-efficacy-in-non-small-cell-lung-cancer-review","Gut microbiota and dietary intervention - affecting immunotherapy efficacy in non-small cell lung cancer - review","","Gut microbiota and dietary intervention: affecting immunotherapy efficacy in non-small cell lung cancer is a scholarly review examining how intestinal microbial composition and diet shape responses to immune checkpoint inhibitors. It outlines the role of the PD-1/PD-L1 immune escape axis in NSCLC and summarizes evidence that gut microbiota characteristics can modulate immunotherapy effectiveness. The review also discusses the impact of antibiotics on immunotherapy outcomes and highlights dietary strategies as a promising adjunct to improve anti-tumor immunity in advanced disease.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/gut-microbiota-and-dietary-intervention-affecting-immunotherapy-efficacy-in-non-small-cell-lung-cancer-review/338929/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/gut-microbiota-and-dietary-intervention-affecting-immunotherapy-efficacy-in-non-small-cell-lung-cancer-review/338929.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why does the PD-1/PD-L1 axis matter in non-small cell lung cancer?","Question",{"text":112,"@type":113},"The PD-1/PD-L1 pathway helps regulate immune homeostasis and can allow cancer cells to evade immune attack. It suppresses antitumor T-cell activity and is implicated in immune escape mechanisms in NSCLC.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does gut microbiota influence immune checkpoint inhibitor efficacy?",{"text":117,"@type":113},"Emerging evidence indicates that host gut microbiota characteristics are associated with how patients respond to ICIs. Studies suggest that complete and favorable gut microbiota profiles support stronger anti-tumor immune responses.",{"name":119,"@type":110,"acceptedAnswer":120},"What roles do antibiotics and dietary intervention play in immunotherapy outcomes?",{"text":121,"@type":113},"Antibiotics can impair immunotherapy efficacy by disrupting gut microbial balance and reducing beneficial microbial populations. Dietary interventions can regulate gut microbiota abundance and are presented as a novel adjunct strategy to improve cancer immunotherapy effectiveness.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338929,1790177658,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","TYPE Review  \nPUBLISHED 01 February 2024  \nDOI 10.3389/fimmu.2024.1343450  \nOPEN ACCESS  \nEDITED BY  \nMaria Gazouli,  \nNational and Kapodistrian University of Athens, Greece  \nREVIEWED BY Ming Yi,  \nZhejiang University, China Dong Tang,  \nYangzhou University, China Lisa Derosa,  \nGustave Roussy Cancer Campus, France  \n*CORRESPONDENCE Jun Chen  \n [chenjun_dmu@126.com](chenjun_dmu@126.com)  \n†These authors have contributed equally to this work  \nRECEIVED 23 November 2023  \nACCEPTED 18 January 2024  \nPUBLISHED 01 February 2024  \nCITATION  \nXin Y, Liu C-G, Zang D and Chen J (2024) Gut microbiota and dietary intervention:  \naffecting immunotherapy efﬁcacy in non–small cell lung cancer.  \nFront. Immunol. 15:1343450 .  \ndoi: 10.3389/fimmu.2024.1343450  \nCOPYRIGHT  \n© 2024 Xin, Liu, Zang and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nGut microbiota and dietary intervention: affecting immunotherapy efﬁcacy in non–small cell lung cancer  \nYu Xin †, Chen-Guang Liu †, Dan Zang † and Jun Chen*  \nDepartment of Oncology, The Second Hospital of Dalian Medical University, Dalian, China  \nNon–small cell lung cancer (NSCLC) accounts for 80–85% of all lung cancers. In recent years, treatment with immune checkpoint inhibitors (ICIs) has gradually improved the survival rate of patients with NSCLC, especially those in the advanced stages. ICIs can block the tolerance pathways that are overexpressed by tumor cells and maintain the protective activity of immune system components against cancer cells. Emerging clinical evidence suggests that gut microbiota may modulate responses to ICIs treatment, possibly holding a key role in tumor immune surveillance and the efﬁcacy of ICIs. Studies have also shown that diet can inﬂuence the abundance of gut microbiota in humans, therefore, dietary interventions and the adjustment of the gut microbiota is a novel and promising treatment strategy for adjunctive cancer therapy. This review comprehensively summarizes the effects of gut microbiota, antibiotics (ATBs), and dietary intervention on the efﬁcacy of immunotherapy in NSCLC, with the aim of informing the development of novel strategies in NSCLC immunotherapy.  \nKEYWORDS  \nnon-small cell lung cancer, gut microbiota, PD-1/PD-L1, antibiotics, dietary intervention  \n1 Introduction  \nLung cancer currently has an extremely high incidence and mortality rate, with non– small cell lung cancer (NSCLC) accounting for 80–85% of all lung cancers. Therefore, clarifying the pathogenesis and treatment of NSCLC is a critical healthcare need. The programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) axis play a key role in physiological immune homeostasis and can serve as a means for cancer cells to evade the immune system (1) . PD-L1 binds its major receptor PD-1 in trans and cis (2, 3) by antagonizing T-cell receptors and CD28 costimulatory signals (4) to suppress antitumor PD-1–positive T-cell function (5) . The PD-1 axis also inhibits the lytic activity against activated cells, including B cells and natural killer (NK) cells (6, 7) . More importantly, PD-1 is highly expressed in regulatory T cells (Tregs), which can be activated and proliferated in  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nthe presence of the ligand (8) . It can also suppress the immune response through increasing the expression of forkhead transcription factor FOXP3, muting the expression of effector cytokines such as interferon-gama (IFN-g), and producing inhibitory cytokines such as transforming growth factor-beta (TGF-b), interleukin (IL)-10, and IL-35 .","cbCaitI8RyPvSHBP","https://ap.wps.com/l/cbCaitI8RyPvSHBP","pdf",2059765,12,"English","# Introduction\n## PD-1/PD-L1 axis in NSCLC\n## Immunotherapy response variability and gut microbiota link\n## Antibiotics and diet as modulators of immunotherapy efficacy","[{\"question\":\"Why does the PD-1/PD-L1 axis matter in non-small cell lung cancer?\",\"answer\":\"The PD-1/PD-L1 pathway helps regulate immune homeostasis and can allow cancer cells to evade immune attack. It suppresses antitumor T-cell activity and is implicated in immune escape mechanisms in NSCLC.\"},{\"question\":\"How does gut microbiota influence immune checkpoint inhibitor efficacy?\",\"answer\":\"Emerging evidence indicates that host gut microbiota characteristics are associated with how patients respond to ICIs. Studies suggest that complete and favorable gut microbiota profiles support stronger anti-tumor immune responses.\"},{\"question\":\"What roles do antibiotics and dietary intervention play in immunotherapy outcomes?\",\"answer\":\"Antibiotics can impair immunotherapy efficacy by disrupting gut microbial balance and reducing beneficial microbial populations. Dietary interventions can regulate gut microbiota abundance and are presented as a novel adjunct strategy to improve cancer immunotherapy effectiveness.\"}]","Gut microbiota and dietary intervention - affecting immunotherapy efficacy in non-small cell lung cancer - review | PDF",1790026594,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c90e5cc988add9cb3489ba60032f947c.webp",983,1389,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89ab90881094b54fe50318feb0759f94.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f8a248102fb383e5a152c3e2557b6a3f.webp",981,1386,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/28273ced0e5ef6c7ce5c77e02ad8494a.webp",980,1385]